Page last updated: 2024-11-08

biguanides and Depression, Endogenous

biguanides has been researched along with Depression, Endogenous in 2 studies

Biguanides: Derivatives of biguanide (the structure formula HN(C(NH)NH2)2) that are primarily used as oral HYPOGLYCEMIC AGENTS for the treatment of DIABETES MELLITUS, TYPE 2 and PREDIABETES.
biguanides : A class of oral hypoglycemic drugs used for diabetes mellitus or prediabetes treatment. They have a structure based on the 2-carbamimidoylguanidine skeleton.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gupta, D1
Thangaraj, D1
Radhakrishnan, M1
Furukawa, S1
Kumagi, T1
Miyake, T1
Ueda, T1
Niiya, T1
Nishino, K1
Murakami, S1
Murakami, M1
Matsuura, B1
Onji, M1

Reviews

1 review available for biguanides and Depression, Endogenous

ArticleYear
Suicide attempt by an overdose of sitagliptin, an oral hypoglycemic agent: a case report and a review of the literature.
    Endocrine journal, 2012, Volume: 59, Issue:4

    Topics: Aged, 80 and over; Biguanides; Blood Glucose; Depressive Disorder; Diabetes Mellitus, Type 2; Dipept

2012

Other Studies

1 other study available for biguanides and Depression, Endogenous

ArticleYear
A novel 5HT3 antagonist 4i (N-(3-chloro-2-methylphenyl)quinoxalin-2-carboxamide) prevents diabetes-induced depressive phenotypes in mice: Modulation of serotonergic system.
    Behavioural brain research, 2016, Jan-15, Volume: 297

    Topics: Animals; Antidepressive Agents; Biguanides; Brain; Depressive Disorder; Diabetes Mellitus, Experimen

2016